Affected by the Ozempic Shortage
Best for anyone who wants medical guidance or has particular health concerns. You’ll get a clear plan, regular check-ins, and a team of professionals by your side.
Struggling with Type 2 Diabetes Treatment?
Living with Type 2 Diabetes can be challenging, especially when it comes to finding the right treatment. Dr. Frank's team is here to help you navigate this journey and find the personalised treatment you need.
Book a Free Consultation
If you have type 2 diabetes and resonate with any of the following situations. Book a free no–obligation call with us today…
Struggling to Meet Diabetes Targets
Best for anyone who wants medical guidance or has particular health concerns. You’ll get a clear plan, regular check-ins, and a team of professionals by your side.
Inconsistent Supply of Treatment
Best for anyone who wants medical guidance or has particular health concerns. You’ll get a clear plan, regular check-ins, and a team of professionals by your side.
Manage your diabetes with Dr. Frank's approach
If you're unable to qualify for NHS treatment with Ozempic (Semaglutide) or Mounjaro (Tirzepatide), Dr. Frank can provide the help you need.
- Your diabetes is well-controlled, which means you don't meet the criteria for treatment eligibility.
- Your BMI and weight do not meet the necessary criteria for eligibility.
- You're not currently taking three tablets for blood sugar control.
How it Works
Mounjaro vs Placebo
Patients lose up to
Patients lose up to
22% body weight¹
All 3 doses of once weekly mounjaro led to clinically meaningful and sustained weight reduction in obese adults
https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
Get Started
Wegovy
Patients lose an average
Patients lose an average
of 15% of their body weight¹
Based on a 68-week clinical study of once-weekly injection of a GLP-1 receptor agonist compared to a placebo with 1961 participants.
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
Get Started
